@bottle thanks for you report.
'Shareholding - 100% retail with 10,300 s/holders.
Can't see a hostile t/over attempt until after mining approvals and DFS - "we will be in a much stronger position by then"
Chairman has dealt with a hostile t/o attempt before.'
Was JM prompted to say this in answer to a question or was it an unsolicited comment? It seems the board is aware of this possibility.
More grist for the rumour mill!
Only halfway on concrete trials is a bit disappointing. JM has said in the Crux interview that he wants concrete in the DFS/BFS so did he stay committed to it being released in Q.2?
On HPA it seems JM is torn between the huge upside of being involved in the development of the technology to get to HPA4N & 5N but also scared off by the big CAPEX requirement. Hopefully he finds the middle ground.
- Forums
- ASX - By Stock
- ADN
- General comments/chat
General comments/chat, page-15813
-
- There are more pages in this discussion • 28,269 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ADN (ASX) to my watchlist
|
|||||
Last
1.6¢ |
Change
-0.001(5.88%) |
Mkt cap ! $49.76M |
Open | High | Low | Value | Volume |
1.6¢ | 1.7¢ | 1.5¢ | $92.09K | 5.787M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 190908 | 1.6¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.7¢ | 3456624 | 11 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 190908 | 0.016 |
43 | 7873041 | 0.015 |
15 | 5136049 | 0.014 |
7 | 2633923 | 0.013 |
6 | 1655833 | 0.012 |
Price($) | Vol. | No. |
---|---|---|
0.017 | 3456624 | 11 |
0.018 | 2962774 | 10 |
0.019 | 3659762 | 9 |
0.020 | 1678444 | 14 |
0.021 | 1397619 | 3 |
Last trade - 16.10pm 15/07/2024 (20 minute delay) ? |
Featured News
ADN (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online